Drug Profile
Research programme: dual carbonic anhydrase IX inhibitors - DualTPharma
Alternative Names: Dual CA IX inhibitors - DualTPharma; Sulfamide-nitroimidazoleLatest Information Update: 05 Aug 2016
Price :
$50
*
At a glance
- Originator DualTPharma
- Class Antineoplastics; Nitroimidazoles; Sulfonamides
- Mechanism of Action Carbonic anhydrase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase Unknown Cancer
Most Recent Events
- 05 Aug 2016 Investigation in Cancer in Netherlands (PO)